Synopsys (SNPS) Tops Q2 EPS by 5c, Offers Q3 & FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Needham & Company Raises Price Target Following Synopsys (SNPS) 2Q Results
May 21, 2015 6:40 AM EDTNeedham & Company maintains a Buy rating on Synopsys (NASDAQ: SNPS), and raised the price target to $53.00 (from $50.00), following the 2Q results. SNPS reported revenue of $557MM and $0.68 EPS, compared to consensus of $$547MM and $0.63.
Needham & Company analyst Richard Valera commented on SNPS, saying, "SNPS delivered solid top and bottom line... More
Synopsys (SNPS) Tops Q2 EPS by 5c
May 20, 2015 4:08 PM EDTSynopsys (NASDAQ: SNPS) reported Q2 EPS of $0.68, $0.05 better than the analyst estimate of $0.63. Revenue for the quarter came in at $557.2 million versus the consensus estimate of $546.46 million.
Synopsys sees Q3 2015 EPS of $0.58-$0.60, versus the consensus of $0.66. Synopsys sees Q3 2015 revenue of $550-560 million,... More
